![]() |
Name |
1-Octadecanethiol
|
Molecular Formula | C18H38S | |
IUPAC Name* |
octadecane-1-thiol
|
|
SMILES |
CCCCCCCCCCCCCCCCCCS
|
|
InChI |
InChI=1S/C18H38S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3
|
|
InChIKey |
QJAOYSPHSNGHNC-UHFFFAOYSA-N
|
|
Synonyms |
octadecane-1-thiol; 1-OCTADECANETHIOL; 2885-00-9; Octadecanethiol; n-Octadecyl mercaptan; Stearyl mercaptan; Octadecyl mercaptan; 1-Mercaptooctadecane; OCTADECANTHIOL; n-octadecanethiol; Octadecanethol; stearylmercaptan; octadecane thiol; 1-octadecanthiol; Octadecylmercaptan; 1-Octadecane thiol; NSC 5545; 1-octadecylmercaptan; EINECS 220-744-1; MFCD00004886; 1-Octadecanethiol, 98%; SCHEMBL25850; DTXSID0062686; NSC5545; AMY11252; NSC-5545; NSC11886; NSC-11886; ZINC86050946; AKOS015843216; DB-047474; 1-Octadecanethiol, purum, >=95.0% (GC); FT-0634531; O0005; D70540; A819631; J-017298; J-523822; 17322-94-0
|
|
CAS | 2885-00-9 | |
PubChem CID | 17905 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 286.6 | ALogp: | 9.4 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 1.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.226 |
Caco-2 Permeability: | -4.945 | MDCK Permeability: | 0.00001070 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.141 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.002 | Plasma Protein Binding (PPB): | 100.43% |
Volume Distribution (VD): | 4.324 | Fu: | 1.85% |
CYP1A2-inhibitor: | 0.189 | CYP1A2-substrate: | 0.177 |
CYP2C19-inhibitor: | 0.285 | CYP2C19-substrate: | 0.06 |
CYP2C9-inhibitor: | 0.076 | CYP2C9-substrate: | 0.949 |
CYP2D6-inhibitor: | 0.163 | CYP2D6-substrate: | 0.073 |
CYP3A4-inhibitor: | 0.163 | CYP3A4-substrate: | 0.035 |
Clearance (CL): | 5.933 | Half-life (T1/2): | 0.048 |
hERG Blockers: | 0.103 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.557 | AMES Toxicity: | 0.023 |
Rat Oral Acute Toxicity: | 0.03 | Maximum Recommended Daily Dose: | 0.043 |
Skin Sensitization: | 0.964 | Carcinogencity: | 0.047 |
Eye Corrosion: | 0.993 | Eye Irritation: | 0.957 |
Respiratory Toxicity: | 0.671 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000428 | ![]() |
0.833 | D00AOJ | ![]() |
0.694 | ||
ENC000527 | ![]() |
0.833 | D07ILQ | ![]() |
0.597 | ||
ENC000284 | ![]() |
0.833 | D00FGR | ![]() |
0.548 | ||
ENC000429 | ![]() |
0.833 | D0Z5SM | ![]() |
0.535 | ||
ENC000285 | ![]() |
0.794 | D05ATI | ![]() |
0.457 | ||
ENC000745 | ![]() |
0.794 | D0O1PH | ![]() |
0.440 | ||
ENC000486 | ![]() |
0.783 | D00STJ | ![]() |
0.420 | ||
ENC000400 | ![]() |
0.783 | D0T9TJ | ![]() |
0.354 | ||
ENC000666 | ![]() |
0.769 | D0P1RL | ![]() |
0.340 | ||
ENC001124 | ![]() |
0.769 | D00MLW | ![]() |
0.324 |